Advances of pathogen inactivation technology in blood components and quality evaluation / 中国输血杂志
Chinese Journal of Blood Transfusion
; (12): 930-935, 2021.
Article
de Zh
| WPRIM
| ID: wpr-1004450
Bibliothèque responsable:
WPRO
ABSTRACT
Through the screening of blood donors, detection of pathogen antigen and antibody, full coverage of nucleic acid detection, the risk of infectious blood transfusion has been reduced to a very low level. Especially, pathogen inactivation technology (PRT) has played an irreplaceable role in ensuring blood safety. The best way to inactivate pathogens is not only to effectively remove the target pathogens in the blood, but also to maintain the activity of active ingredients in the blood to the maximum extent, and it doesn′t affect the effect of blood therapy. In this paper, the development of pathogen inactivation technology is summarized, and the influence of pathogen inactivation treatment on the quality of blood components is discussed. It provides references for improving or developing new processing technology.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Blood Transfusion
Année:
2021
Type:
Article